Back to Search
ADOLFO GALVEZ, M.D.
M.D.
Family Medicine Physician
NPI: 1053464164Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Erlotinib has moderate single-agent activity in chemotherapy-naïve castration-resistant prostate cancer: final results of a phase II trial.
PMID 19616281·Urology·2009
3-trial
Simultaneous inactivation of Par-4 and PTEN in vivo leads to synergistic NF-kappaB activation and invasive prostate carcinoma.
PMID 19470463·Proc Natl Acad Sci U S A·2009
7-preclinical
Multilocus sequence typing of Enterococcus faecalis from vegetable foods reveals two new sequence types.
PMID 19272006·Foodborne Pathog Dis·2009
4-observational
Protein kinase Czeta represses the interleukin-6 promoter and impairs tumorigenesis in vivo.
PMID 18955501·Mol Cell Biol·2009
7-preclinical
Horner syndrome associated with ipsilateral facial and extremity anhydrosis.
PMID 18769279·J Neuroophthalmol·2008
5-case
Par-4 inhibits Akt and suppresses Ras-induced lung tumorigenesis.
PMID 18650932·EMBO J·2008
7-preclinical
Detection of ebp (endocarditis- and biofilm-associated pilus) genes in enterococcal isolates from clinical and non-clinical origin.
PMID 18571263·Int J Food Microbiol·2008
8-other
Application of bacteriocins in the control of foodborne pathogenic and spoilage bacteria.
PMID 18568851·Crit Rev Biotechnol·2008
6-review
The interaction of genetic polymorphisms with lifestyle factors: implications for the dietary prevention of prostate cancer.
PMID 18444164·Nutr Cancer·2008
6-review
The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis.
PMID 18394557·Cancer Cell·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1002 JOHN MOORE RD
BRANDON, FL 33511 - Phone
- (813) 684-6771
Quick Facts
- NPI
- 1053464164
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile